We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+17.32%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$481M
AUM Growth
+$50.2M
Cap. Flow
+$37.7M
Cap. Flow %
7.84%
Top 10 Hldgs %
100%
Holding
8
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
EYPT icon
EyePoint Inc
EYPT
+$37.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 98.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EYPT icon
1
EyePoint Inc
EYPT
$1.13B
$150M 31.11%
4,190,396
+1,643,357
+65% +$37.7M
AXGN icon
2
Axogen
AXGN
$2.61B
$137M 28.44%
3,711,111
CORI
3
DELISTED
Corium International, Inc.
CORI
$89M 18.5%
9,353,304
RVNC
4
DELISTED
Revance Therapeutics, Inc.
RVNC
$83M 17.27%
3,342,047
MNOV icon
5
MediciNova
MNOV
$65M
$14.6M 3.04%
1,170,370
ELGX
6
DELISTED
Endologix Inc
ELGX
$6.68M 1.39%
125,747
GYRE icon
7
Gyre Therapeutics
GYRE
$704M
$861K 0.18%
10,483
ACUR
8
DELISTED
Acura Pharmaceuticals
ACUR
$372K 0.08%
1,956,397

Similar funds

Essex Woodlands Management's Q3 2018 Portfolio in Review

As of Q3 2018, Essex Woodlands Management held 8 positions worth $481M, up 12% from $431M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management deployed $37.7M of net new capital in Q3 2018, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 97% a quarter earlier.

  • Essex Woodlands Management added most to EyePoint Inc in Q3 2018, an estimated $37.7M increase.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $481M portfolio in Q3 2018.
  • Essex Woodlands Management opened 0 new positions and closed 0 in Q3 2018.
  • Essex Woodlands Management's portfolio value rose 12% quarter-over-quarter to $481M.

Based on Essex Woodlands Management's 13F filing for Q3 2018, filed 14 Nov 2018.